Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2025	Feb. 02, 2024	Feb. 03, 2023
Cash flows from operating activities:
Net earnings	$ 6,957	$ 7,726	$ 6,437
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	1,972	1,923	1,981
Noncash lease expense	520	499	530
Deferred income taxes	9	6	(239)
Asset impairment and loss on property - net	5	83	2,118
(Gain)/loss on sale of business	(177)	(79)	421
Share-based payment expense	221	210	223
Changes in operating assets and liabilities:
Merchandise inventory – net	(514)	1,637	(2,594)
Other operating assets	93	182	56
Accounts payable	633	(1,820)	(549)
Other operating liabilities	(94)	(2,227)	205
Net cash provided by operating activities	9,625	8,140	8,589
Cash flows from investing activities:
Purchases of investments	(1,286)	(1,785)	(1,189)
Proceeds from sale/maturity of investments	1,204	1,722	1,174
Capital expenditures	(1,927)	(1,964)	(1,829)
Proceeds from sale of property and other long-term assets	105	53	45
Proceeds from sale of business	177	100	491
Other – net	(11)	(27)	(1)
Net cash used in investing activities	(1,738)	(1,901)	(1,309)
Cash flows from financing activities:
Net change in commercial paper	0	(499)	499
Net proceeds from issuance of debt	0	2,983	9,667
Repayment of debt	(545)	(601)	(867)
Proceeds from issuance of common stock under share-based payment plans	159	141	151
Cash dividend payments	(2,566)	(2,531)	(2,370)
Repurchases of common stock	(4,053)	(6,138)	(14,124)
Other – net	(42)	(21)	(5)
Net cash used in financing activities	(7,047)	(6,666)	(7,049)
Effect of exchange rate changes on cash	0	0	(16)
Net increase/(decrease) in cash and cash equivalents	840	(427)	215
Cash and cash equivalents, beginning of year	921	1,348	1,133
Cash and cash equivalents, end of year	$ 1,761	$ 921	$ 1,348